Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Lymphoma

Free Subscription Articles published in Blood Retrieve available abstracts of 264 articles: HTML format

Single Articles

May 2008
1. DAVE SS
   Follicular lymphoma and the microenvironment.
   Blood. 2008;111:4427-8.
   PubMed     Related articles   
   
   
   April 2008
2. MALUMBRES R , Chen J, Tibshirani R, Johnson NA, et al
   Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. SCHOLLKOPF C , Melbye M, Munksgaard L, Smedby KE, et al
   Borrelia infection and risk of non-Hodgkin lymphoma.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. RENUKARADHYA GJ , Khan MA, Vieira M, Du W, et al
   Type I NKT cells protect (and Type II NKT cells suppress) the host's innate antitumor immune response to a B cell lymphoma.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. KHOURI IF , McLaughlin P, Saliba RM, Hosing C, et al
   8-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide and rituximab.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. HAGENBEEK A , Gadeberg O, Johnson P, Pedersen LM, et al
   First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase I/II trial.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. SAVAGE KJ , Harris NL, Vose JM, Ullrich F, et al
   ALK-negative anaplastic large-cell lymphoma (ALCL) is clinically and immunophenotypically different from both ALK-positive ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
8. ANTICA M , Sain LC, Kapitanovic S, Matulic M, et al
   Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma.
   Blood. 2008;111:3296-7.
   PubMed     Related articles   
   
   
   
9. KITADA S , Kress CL, Krajewska M, Jia L, et al
   Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).
   Blood. 2008;111:3211-9.
   PubMed     Related articles    Abstract available
   
   
   
10. BRENNER H , Gondos A, Pulte D
    Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients.
    Blood. 2008;111:2977-83.
    PubMed     Related articles    Abstract available
    
    
    
11. DAL COL J , Zancai P, Terrin L, Guidoboni M, et al
    Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. BROWN PJ , Ashe SL, Leich E, Burek C, et al
    Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.
    Blood. 2008;111:2816-24.
    PubMed     Related articles    Abstract available
    
    
    February 2008
13. TASKINEN M , Karjalainen-Lindsberg ML, Leppa S
    Prognostic influence of tumor-infiltrating mast cells in follicular lymphoma patients treated with rituximab and CHOP.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. MITTAL S , Marshall NA, Duncan L, Culligan DJ, et al
    Local and systemic induction of CD4+CD25+ regulatory T cell population by non-Hodgkin's lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. SCHEEREN FA , Diehl SA, Smit LA, Beaumont T, et al
    IL-21 is expressed in Hodgkin Lymphoma and activates STAT5; evidence that activated STAT5 is required for Hodgkin Lymphomagenesis.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. PAOLUZZI L , Gonen M, Gardner JR, Mastrella J, et al
    Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. MOURAD N , Mounier N, Briere J, Raffoux E, et al
    Clinical, biological and pathological features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. SKIBOLA CF , Nieters A, Bracci PM, Curry JD, et al
    A functional TNFRSF5 gene variant is associated with risk of lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. ZHAO WL , Janin A, Chen SJ
    Response: Multiple role of PRDM1{beta} involvement in diffuse large B-cell lymphoma.
    Blood. 2008;111:2489-90.
    PubMed     Related articles   
    
    
    
20. FELDMAN AL , Arber DA, Pittaluga S, Martinez A, et al
    Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. EKSTROM SMEDBY K , Vajdic CM, Falster M, Engels EA, et al
    Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. BLUHM EC , Ronckers C, Hayashi RJ, Neglia JP, et al
    Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. THOMPSON JA , Fisher RI, Leblanc M, Forman SJ, et al
    Total body irradiation, etoposide, cyclophosphamide and autologous peripheral blood stem cell transplantation followed by randomization to therapy with Interleukin-2 versus observation for patients with non-Hodgkin's lymphoma: results of a phase III rand
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. HERENS C , Lambert F, Quintanilla-Martinez L, Bisig B, et al
    Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression.
    Blood. 2008;111:1745-6.
    PubMed     Related articles   
    
    
    
25. DING BB , Yu JJ, Yu RY, Mendez LM, et al
    Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.
    Blood. 2008;111:1515-23.
    PubMed     Related articles    Abstract available
    
    
    January 2008
26. LADETTO M , De Marco F, Benedetti F, Vitolo U, et al
    Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an over-all survi
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. ZHAO WL , Liu YY, Zhang QL, Wang L, et al
    PRDM1/BLIMP-1 is involved in chemoresistance of T-cell lymphoma and downregulated by the proteasome inhibitor.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. GUASPARRI I , Bubman D, Cesarman E
    EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. MOARBESS G , El-Hajj H, Kfoury Y, El-Sabban ME, et al
    EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase dependent apoptosis in T cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. YAMAMOTO R , Nishikori M, Kitawaki T, Sakai T, et al
    PD-1-PD-1-ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. VELLENGA E , van Putten WL, van 't Veer MB, Zijlstra JM, et al
    Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
    Blood. 2008;111:537-43.
    PubMed     Related articles    Abstract available
    
    
    
32. HAAS J , Schopp L, Storch-Hagenlocher B, Fritzsching B, et al
    Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis.
    Blood. 2008;111:761-6.
    PubMed     Related articles    Abstract available
    
    
    
33. STAGNI V , di Bari MG, Cursi S, Condo I, et al
    ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.
    Blood. 2008;111:829-37.
    PubMed     Related articles    Abstract available
    
    
    
34. TUN HW , Personett D, Baskerville KA, Menke DM, et al
    Pathway analysis of primary central nervous system lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
35. BYERS RJ , Sakhinia E, Joseph P, Glennie C, et al
    Clinical quantitation of immune signature in follicular lymphoma by RT-PCR based gene expression profiling.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. BOWER M , Stebbing J, Tuthill M, Campbell V, et al
    Immunological recovery in survivors following chemotherapy for AIDS related non Hodgkin's lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. MONTES-MORENO S , Roncador G, Maestre L, Martinez N, et al
    Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas.
    Blood. 2008;111:351-8.
    PubMed     Related articles    Abstract available
    
    
    December 2007
38. LAM LT , Wright G, Davis RE, Lenz G, et al
    Cooperative signaling through the STAT3 and NF-{kappa}B pathways in subtypes of diffuse large B cell lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. NAVARRO A , Gaya A, Martinez A, Urbano-Ispizua A, et al
    MicroRNA expression profiling in classical Hodgkin lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. OFLAZOGLU E , Stone IJ, Gordon KA, Grewal IS, et al
    Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30.
    Blood. 2007;110:4370-2.
    PubMed     Related articles    Abstract available
    
    
    
41. O'HARA A , Vahrson W, Dittmer DP
    Gene alteration, pre- and mature micro RNA changes contribute to the miRNA signature of Primary Effusion Lymphoma (PEL).
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. DETERMANN O , Hoster E, Ott G, Bernd HW, et al
    Ki-67 predicts outcome in advanced stage mantle cell lymphoma patients treated with anti-CD20 immunochemo-therapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. COZEN W , Gill PS, Salam MT, Nieters A, et al
    Interleukin-2, interleukin-12 and interferon-{gamma} levels and risk of young adult Hodgkin lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. MA Y , Visser L, Roelofsen H, de Vries M, et al
    Proteomics analysis of Hodgkin lymphoma: Identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
45. TRAVERSE-GLEHEN A , Baseggio L, Callet-Bauchu E, Morel D, et al
    Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinico-pathological and molecular entity?
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. PATHAN NI , Chu P, Hariharan K, Cheney C, et al
    Mediation of apoptosis by and anti-tumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
47. QU Z , Goldenberg DM, Cardillo TM, Shi V, et al
    Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. KIM SW , Oleksyn DW, Rossi RM, Jordan CT, et al
    Protein kinase C-associated kinase PKK is required for NF-{kappa}B signaling and survival in diffuse large B-cell lymphoma cells.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. ORTEGA-PAINO E , Fransson J, Ek S, Borrebaeck CA, et al
    Functionally-associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. CHEN L , Monti S, Juszczynski P, Daley J, et al
    SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. MANCAO C , Hammerschmidt W
    Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival.
    Blood. 2007;110:3715-21.
    PubMed     Related articles    Abstract available
    
    
    
52. FRANKI SN , Steward KK, Betting DJ, Kafi K, et al
    Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B cell lymphoma in vivo.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. RODRIGUEZ-ANTONA C , Leskela S, Zajac M, Cuadros M, et al
    Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas.
    Blood. 2007;110:3345-51.
    PubMed     Related articles    Abstract available
    
    
    October 2007
54. DOOLITTLE ND , Abrey LE, Shenkier TN, Siegal T, et al
    Brain parenchyma involvement as isolated central nervous system (CNS) relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. HOSTER E , Dreyling M, Klapper W, Gisselbrecht C, et al
    A new prognostic index (MIPI) for patients with advanced stage mantle cell lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. FOX E , Razzouk BI, Widemann BC, Xiao S, et al
    Phase I trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia including acute promyelocytic leukemia or lymphoma A collaborative study of The Pediatric Oncology Branch, National Cancer
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. LE DELEY MC , Reiter A, Williams D, Delsol G, et al
    Prognostic factors in childhood anaplastic large cell lymphoma : results of a large European Intergroup Study.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. SCHULZ H , Rehwald U, Morschhauser F, Elter T, et al
    Rituximab in relapsed lymphocyte-predominant Hodgkin Lymphoma: Long-term results of a phase-II trial of the German Hodgkin Lymphoma Study Group (GHSG).
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. REIMANN M , Loddenkemper C, Rudolph C, Schildhauer I, et al
    The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.
    Blood. 2007;110:2996-3004.
    PubMed     Related articles    Abstract available
    
    
    
60. WILLEMZE R , Jansen PM, Cerroni L, Berti E, et al
    Subcutaneous panniculitis-like T-cell lymphoma: definition, classification and prognostic factors. An EORTC Cutaneous Lymphoma Group study of 83 cases.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
61. EK S , Dictor M, Jerkeman M, Jirstrom K, et al
    Nuclear expression of the non-B cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. CILLESSEN SA , Reed JC, Welsh K, Pinilla C, et al
    Small-molecule XIAP antagonist restores caspase-9-mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. KWEE TC , Kwee RM, Nievelstein RA
    Imaging in staging of malignant lymphoma: a systematic review.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. SORROR ML , Storer BE, Maloney DG, Sandmaier BM, et al
    Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. SHACHAF CM , Perez OD, Youssef S, Fan AC, et al
    Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.
    Blood. 2007;110:2674-84.
    PubMed     Related articles    Abstract available
    
    
    
66. SPAULDING C , Reschly EJ, Zagort DE, Yashiro-Ohtani Y, et al
    Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas.
    Blood. 2007;110:2650-8.
    PubMed     Related articles    Abstract available
    
    
    
67. PEREZ-PERSONA E , Vidriales MB, Mateo G, Garcia-Sanz R, et al
    New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.
    Blood. 2007;110:2586-92.
    PubMed     Related articles    Abstract available
    
    
    
68. DAVENPORT EL , Moore HE, Dunlop AS, Sharp SY, et al
    Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells.
    Blood. 2007;110:2641-9.
    PubMed     Related articles    Abstract available
    
    
    
69. GOEL A , Carlson SK, Classic KL, Greiner S, et al
    Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.
    Blood. 2007;110:2342-50.
    PubMed     Related articles    Abstract available
    
    
    
70. SAVOLDO B , Rooney CM, Di Stasi A, Abken H, et al
    Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
    Blood. 2007;110:2620-30.
    PubMed     Related articles    Abstract available
    
    
    September 2007
71. DU X , Nagata S, Ise T, Stetler-Stevenson M, et al
    FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia and B-cell non-Hodgkin's lymphoma as a target of immunotoxins.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. SIENIAWSKI M , Reineke T, Nogova L, Josting A, et al
    Fertility in male patients with advanced Hodgkin Lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. DE BRUIN ML , Huisbrink J, Hauptmann M, Kuenen MA, et al
    Treatment-related risk factors for premature menopause following Hodgkin's lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
74. BESSETTE K , Lang M, Fava RA, Grundy M, et al
    A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. WIES E , Mori Y, Hahn A, Kremmer E, et al
    The viral interferon regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. YOUNG KH , Weisenburger DD, Dave B, Smith L, et al
    Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. FREDRIKSEN AB , Bogen B
    Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences.
    Blood. 2007;110:1797-805.
    PubMed     Related articles    Abstract available
    
    
    
78. PEI XY , Dai Y, Tenorio S, Lu J, et al
    MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism.
    Blood. 2007;110:2092-101.
    PubMed     Related articles    Abstract available
    
    
    
79. YANG Y , MacLeod V, Dai Y, Khotskaya-Sample Y, et al
    The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
    Blood. 2007;110:2041-8.
    PubMed     Related articles    Abstract available
    
    
    
80. DAHLE J , Borrebaek J, Jonasdottir TJ, Hjelmerud AK, et al
    Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate.
    Blood. 2007;110:2049-56.
    PubMed     Related articles    Abstract available
    
    
    
81. LESEUX L , Laurent G, Laurent C, Rigo M, et al
    PKC zeta-mTOR pathway: a new target for Rituximab therapy in follicular lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. CERHAN JR , Ansell SM, Fredericksen ZS, Kay NE, et al
    Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. LU X , Chen J, Malumbres R, Cubedo Gil E, et al
    HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. QIAN J , Xie J, Hong S, Yang J, et al
    Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.
    Blood. 2007;110:1587-94.
    PubMed     Related articles    Abstract available
    
    
    
85. TAI YT , Fulciniti M, Hideshima T, Song W, et al
    Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis.
    Blood. 2007;110:1656-63.
    PubMed     Related articles    Abstract available
    
    
    
86. LWIN T , Hazlehurst LA, Dessureault S, Lai R, et al
    Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
    Blood. 2007;110:1631-8.
    PubMed     Related articles    Abstract available
    
    
    August 2007
87. LIU Q , Zhao X, Frissora F, Ma Y, et al
    FTY720 demonstrates promising pre-clinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. DANIEL D , Yang B, Lawrence DA, Totpal K, et al
    Cooperation of the pro-apoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin's lymphoma xenografts.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. FLAVELL JR , Baumforth KR, Wood VH, Davies GL, et al
    Downregulation of the TGF-Beta target gene, PTPRK, by the epstein-barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin's lymphoma cells.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
90. SEAM P , Juweid ME, Cheson BD
    The role of FDG-PET scans in patients with lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. LOFFLER D , Brocke-Heidrich K, Pfeifer G, Stocsits C, et al
    Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.
    Blood. 2007;110:1330-3.
    PubMed     Related articles    Abstract available
    
    
    
92. TERPOS E , Sezer O, Croucher P, Dimopoulos MA, et al
    Myeloma bone disease and proteasome inhibition therapies.
    Blood. 2007;110:1098-104.
    PubMed     Related articles    Abstract available
    
    
    
93. STABER PB , Vesely P, Haq N, Ott RG, et al
    The oncoprotein NPM-ALK of anaplastic large cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. VAN RHEE F , Bolejack V, Hollmig K, Pineda-Roman M, et al
    High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.
    Blood. 2007;110:827-32.
    PubMed     Related articles    Abstract available
    
    
    July 2007
95. PALS ST , de Gorter DJ, Spaargaren M
    Lymphoma dissemination: the other face of lymphocyte homing.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
96. MOTTOK A , Renne C, Willenbrock K, Hansmann ML, et al
    Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
97. CHEMNITZ JM , Eggle D, Driesen J, Classen S, et al
    RNA-fingerprints provide direct evidence for the inhibitory role of TGF{beta} and PD-1 on CD4+ T cells in Hodgkin's lymphoma.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. SHIN J , Monti S, Aires DJ, Duvic M, et al
    Lesional gene expression profiling in cutaneous T cell lymphoma reveals natural clusters associated with disease outcome.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. ZHANG B , Wang Z, Li T, Tsitsikov EN, et al
    NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.
    Blood. 2007;110:743-51.
    PubMed     Related articles    Abstract available
    
    
    
100. KIZILTEPE T , Hideshima T, Ishitsuka K, Ocio EM, et al
     JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells.
     Blood. 2007;110:709-18.
     PubMed     Related articles    Abstract available
     
     
     
101. NIENS M , Jarrett RF, Hepkema B, Nolte IM, et al
     HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV-positive Hodgkin lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
102. YANG ZZ , Novak AJ, Ziesmer SC, Witzig TE, et al
     CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25- T cells.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. GALICIER L , Fieschi C, Borie R, Meignin V, et al
     Intensive chemotherapy regimen (LMB 86) for Saint Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
104. BOLLARD CM , Gottschalk S, Leen AM, Weiss H, et al
     Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
105. KAWAMATA N , Chen J, Koeffler HP
     SAHA (vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
106. SHEN L , Au WY, Guo T, Wong KY, et al
     Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK)-cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation.
     Blood. 2007;110:469-70.
     PubMed     Related articles   
     
     
     
107. GIULIANI N , Morandi F, Tagliaferri S, Lazzaretti M, et al
     The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients.
     Blood. 2007;110:334-8.
     PubMed     Related articles    Abstract available
     
     
     
108. CHEN H , Gordon MS, Campbell RA, Li M, et al
     Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth.
     Blood. 2007;110:287-95.
     PubMed     Related articles    Abstract available
     
     
     
109. LIU J , Hamrouni A, Wolowiec D, Coiteux V, et al
     Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.
     Blood. 2007;110:296-304.
     PubMed     Related articles    Abstract available
     
     
     
110. BOULLAND ML , Marquet J, Molinier-Frenkel V, Moller P, et al
     Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation.
     Blood. 2007;110:220-7.
     PubMed     Related articles    Abstract available
     
     
     June 2007
111. CHUNG Y , Qin H, Kang CY, Kim S, et al
     An NKT-mediated autologous vaccine generates CD4 T cell-dependent potent anti-lymphoma immunity.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. GALLAMINI A , Zaja F, Patti C, Billio A, et al
     Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL prospective multicenter trial.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
113. SCOTT K , Adamson PJ, Barrans SL, Worrillow LJ, et al
     RAG1 and BRCA2 polymorphisms in non-Hodgkin lymphoma.
     Blood. 2007;109:5522-3.
     PubMed     Related articles   
     
     
     
114. POPESCU MC , Robb RJ, Batenjany MM, Boni LT, et al
     A novel proteoliposomal vaccine elicits potent antitumor immunity in mice.
     Blood. 2007;109:5407-10.
     PubMed     Related articles    Abstract available
     
     
     
115. TRUDEL S , Li ZH, Rauw J, Tiedemann RE, et al
     Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma.
     Blood. 2007;109:5430-8.
     PubMed     Related articles    Abstract available
     
     
     
116. GUO Z , Dose M, Kovalovsky D, Chang R, et al
     Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation.
     Blood. 2007;109:5463-72.
     PubMed     Related articles    Abstract available
     
     
     
117. ZHOU HJ , Pham LV, Tamayo AT, Lin-Lee YC, et al
     Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B cell Lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. PAREKH S , Polo JM, Shaknovich R, Juszczynski P, et al
     BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. MARIE-CARDINE A , Huet D, Ortonne N, Remtoula N, et al
     Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome.
     Blood. 2007;109:5064-5.
     PubMed     Related articles   
     
     
     
120. MAHTOUK K , Hose D, Raynaud P, Hundemer M, et al
     Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma.
     Blood. 2007;109:4914-23.
     PubMed     Related articles    Abstract available
     
     
     
121. BAHLIS NJ , King AM, Kolonias D, Carlson LM, et al
     CD28-mediated regulation of multiple myeloma cell proliferation and survival.
     Blood. 2007;109:5002-10.
     PubMed     Related articles    Abstract available
     
     
     
122. ZHAN F , Colla S, Wu X, Chen B, et al
     CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.
     Blood. 2007;109:4995-5001.
     PubMed     Related articles    Abstract available
     
     
     
123. PANTELIAS A , Pagel JM, Hedin N, Saganic L, et al
     Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas.
     Blood. 2007;109:4980-7.
     PubMed     Related articles    Abstract available
     
     
     
124. SPISEK R , Charalambous A, Mazumder A, Vesole DH, et al
     Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.
     Blood. 2007;109:4839-45.
     PubMed     Related articles    Abstract available
     
     
     
125. YU D , Carroll M, Thomas-Tikhonenko A
     p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors.
     Blood. 2007;109:4936-43.
     PubMed     Related articles    Abstract available
     
     
     May 2007
126. OLSEN E , Vonderheid E, Pimpinelli N, Willemze R, et al
     Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment o
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
127. GALIETTA A , Gunby RH, Redaelli S, Stano P, et al
     NPM/ALK binds and phosphorylates the RNA/DNA binding protein PSF in anaplastic large cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
128. AMIN HM , Lai R
     Pathobiology of ALK+ anaplastic large-cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
129. WEI X , Kee BL
     Growth factor independent 1B (Gfi1b) is an E2A target gene that modulates Gata3 in T-cell lymphomas.
     Blood. 2007;109:4406-14.
     PubMed     Related articles    Abstract available
     
     
     
130. COLLA S , Zhan F, Xiong W, Wu X, et al
     The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells.
     Blood. 2007;109:4470-7.
     PubMed     Related articles    Abstract available
     
     
     
131. SEHN LH , Donaldson J, Filewich A, Fitzgerald C, et al
     Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting.
     Blood. 2007;109:4171-3.
     PubMed     Related articles    Abstract available
     
     
     
132. DE FALCO G , Leucci E, Lenze D, Piccaluga PP, et al
     Gene expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt's lymphoma cell lines and primary tumors.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
133. KNOOPS L , Haas R, de Kemp S, Majoor D, et al
     In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
134. CHUNG R , Lai R, Wei P, Lee J, et al
     Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the international prognostic index.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
135. VAN BERGEN CA , Kester MG, Jedema I, Heemskerk MH, et al
     Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene.
     Blood. 2007;109:4089-96.
     PubMed     Related articles    Abstract available
     
     
     
136. LUCIANO F , Krajewska M, Ortiz-Rubio P, Krajewski S, et al
     Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma.
     Blood. 2007;109:3849-55.
     PubMed     Related articles    Abstract available
     
     
     
137. SHI Y , Reiman T, Li W, Maxwell CA, et al
     Targeting aurora kinases as therapy in multiple myeloma.
     Blood. 2007;109:3915-21.
     PubMed     Related articles    Abstract available
     
     
     
138. HURT EM , Thomas SB, Peng B, Farrar WL, et al
     Integrated molecular profiling of SOD2 expression in multiple myeloma.
     Blood. 2007;109:3953-62.
     PubMed     Related articles    Abstract available
     
     
     
139. KASHKAR H , Deggerich A, Seeger JM, Yazdanpanah B, et al
     NF-kappaB-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs.
     Blood. 2007;109:3982-8.
     PubMed     Related articles    Abstract available
     
     
     April 2007
140. DARBY SC , Kan SW, Spooner RJ, Giangrande PL, et al
     Mortality rates, life expectancy and causes of death in people with haemophilia A or B in the United Kingdom who were not infected with HIV.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
141. GANDHI MK , Moll G, Smith C, Dua U, et al
     Galectin-1 mediated suppression of EBV-specific T-cell immunity in classical Hodgkin's Lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. SINGHAL S , Stein R, Vickrey E, Mehta J, et al
     The serum-free light chain assay cannot replace 24-hour urine protein estimation in patients with plasma cell dyscrasias.
     Blood. 2007;109:3611-2.
     PubMed     Related articles   
     
     
     
143. CHNG WJ , Mulligan G, Bryant B, Bergsagel L, et al
     Survival of genetic subtypes of relapsed myeloma may be modulated by secondary events.
     Blood. 2007;109:3610-1.
     PubMed     Related articles   
     
     
     
144. AVET-LOISEAU H , Attal M, Moreau P, Charbonnel C, et al
     Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome.
     Blood. 2007;109:3489-95.
     PubMed     Related articles    Abstract available
     
     
     
145. MULLIGAN G , Mitsiades C, Bryant B, Zhan F, et al
     Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.
     Blood. 2007;109:3177-88.
     PubMed     Related articles    Abstract available
     
     
     
146. CRAWLEY C , Iacobelli S, Bjorkstrand B, Apperley JF, et al
     Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning.
     Blood. 2007;109:3588-94.
     PubMed     Related articles    Abstract available
     
     
     
147. LEVENTAKI V , Drakos E, Medeiros LJ, Lim MS, et al
     NPM-ALK oncogenic kinase promotes cell cycle progression through activation of JNK/cJun signaling in anaplastic large cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. DU W , Hattori Y, Yamada T, Matsumoto K, et al
     NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor.
     Blood. 2007;109:3042-9.
     PubMed     Related articles    Abstract available
     
     
     
149. PALUMBO A , Ambrosini MT, Benevolo G, Pregno P, et al
     Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma.
     Blood. 2007;109:2767-72.
     PubMed     Related articles    Abstract available
     
     
     
150. STANDAL T , Abildgaard N, Fagerli UM, Stordal B, et al
     HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma.
     Blood. 2007;109:3024-30.
     PubMed     Related articles    Abstract available
     
     
     
151. ALSAYED Y , Ngo H, Runnels J, Leleu X, et al
     Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.
     Blood. 2007;109:2708-17.
     PubMed     Related articles    Abstract available
     
     
     March 2007
152. PARK S , Lee J, Ko YH, Han A, et al
     The impact of the Epstein-Barr Virus status on clinical outcome in diffuse large B cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
153. DAMM-WELK C , Busch K, Burkhardt B, Schieferstein J, et al
     Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK positive anaplastic large cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
154. MORTON LM , Turner JJ, Cerhan JR, Linet MS, et al
     Proposed classification of lymphoid neoplasms for epidemiologic research from the International Lymphoma Epidemiology Consortium (InterLymph).
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
155. MORSCHHAUSER F , Illidge T, Huglo D, Martinelli G, et al
     Efficacy and safety of yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem cell transplantation.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
156. LIU YY , Leboeuf C, Shi JY, Li JM, et al
     Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
157. POLSON AG , Yu SF, Elkins K, Zheng B, et al
     Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin's lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
158. BHARDWAJ A , Sethi G, Vadhan-Raj S, Bueso-Ramos C, et al
     Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.
     Blood. 2007;109:2293-302.
     PubMed     Related articles    Abstract available
     
     
     
159. CHANAN-KHAN AA , Kaufman JL, Mehta J, Richardson PG, et al
     Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study.
     Blood. 2007;109:2604-6.
     PubMed     Related articles    Abstract available
     
     
     
160. PERRINE SP , Hermine O, Small T, Suarez F, et al
     A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
     Blood. 2007;109:2571-8.
     PubMed     Related articles    Abstract available
     
     
     
161. SHAUGHNESSY JD JR , Zhan F, Burington BE, Huang Y, et al
     A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
     Blood. 2007;109:2276-84.
     PubMed     Related articles    Abstract available
     
     
     
162. ISHAM CR , Tibodeau JD, Jin W, Xu R, et al
     Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress.
     Blood. 2007;109:2579-88.
     PubMed     Related articles    Abstract available
     
     
     
163. ARMITAGE JO
     How I treat patients with diffuse large B-Cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
164. DEANGELO DJ , Yu D, Johnson JL, Coutre SE, et al
     Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: cancer and leukemia group B study 19801.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
165. CHEN G , Ghosh P, Osawa H, Sasaki CY, et al
     Resistance to TGF-{beta}1 correlated with aberrant expression of TGF-{beta} receptor II in human B-cell lymphoma cell lines.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
166. NEELAPU SS , Gause BL, Harvey L, Lee ST, et al
     A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
167. KIM YH , Willemze R, Pimpinelli N, Whittaker S, et al
     TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Re
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
168. PINYOL M , Bea S, Pla L, Ribrag V, et al
     Inactivation of RB1 in mantle cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
169. SEHN LH , Berry B, Chhanabhai M, Fitzgerald C, et al
     The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
     Blood. 2007;109:1857-61.
     PubMed     Related articles    Abstract available
     
     
     
170. JAKOB C , Egerer K, Liebisch P, Turkmen S, et al
     Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma.
     Blood. 2007;109:2100-5.
     PubMed     Related articles    Abstract available
     
     
     
171. FENG R , Anderson G, Xiao G, Elliott G, et al
     SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.
     Blood. 2007;109:2130-8.
     PubMed     Related articles    Abstract available
     
     
     
172. CHENG SH , Ng MH, Lau KM, Liu HS, et al
     4q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4.
     Blood. 2007;109:2089-99.
     PubMed     Related articles    Abstract available
     
     
     
173. YACCOBY S , Ling W, Zhan F, Walker R, et al
     Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.
     Blood. 2007;109:2106-11.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
174. CATELLANI S , Poggi A, Bruzzone A, Dadati P, et al
     Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins.
     Blood. 2007;109:2078-85.
     PubMed     Related articles    Abstract available
     
     
     February 2007
175. CERHAN JR , Wang S, Maurer MJ, Ansell SM, et al
     Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
176. KELLY PN , Puthalakath H, Adams JM, Strasser A, et al
     Endogenous bcl-2 is not required for the development of E{micro}-myc-induced B cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
177. WANG M , Zhang L, Han X, Yang J, et al
     Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
178. FRENCH RR , Taraban VY, Crowther GR, Rowley TF, et al
     Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
179. FORD RJ , Shen L, Lin-Lee YC, Pham LV, et al
     Development of a murine model for blastoid variant mantle cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
180. KIM YH , Duvic M, Obitz E, Gniadecki R, et al
     Clinical efficacy of zanolimumab (HuMax-CD4): two Phase II studies in refractory cutaneous T-cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
181. GRIBBEN JG
     How I treat indolent lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
182. NATKUNAM Y , Zhao S, Mason DY, Chen J, et al
     The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
     Blood. 2007;109:1636-42.
     PubMed     Related articles    Abstract available
     
     
     
183. SHARKEY J , Khong T, Spencer A
     PKC412 demonstrates JNK-dependent activity against human multiple myeloma cells.
     Blood. 2007;109:1712-9.
     PubMed     Related articles    Abstract available
     
     
     
184. PODAR K , Raab MS, Zhang J, McMillin D, et al
     Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).
     Blood. 2007;109:1669-77.
     PubMed     Related articles    Abstract available
     
     
     
185. ZHAN F , Barlogie B, Arzoumanian V, Huang Y, et al
     Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
     Blood. 2007;109:1692-700.
     PubMed     Related articles    Abstract available
     
     
     
186. WIESTNER A , Tehrani M, Chiorazzi M, Wright G, et al
     Point mutations and genomic deletions in Cyclin D1 create stable truncated mRNAs that are associated with increased proliferation rate and shorter survival in mantle cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
187. NYMAN H , Adde M, Karjalainen-Lindsberg ML, Taskinen M, et al
     Prognostic impact of immunohistochemically-defined germinal centre phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
188. DE LEVAL L , Rickman DS, Thielen C, de Reynies A, et al
     The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T cells (TFH).
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
189. DIB A , Barlogie B, Shaughnessy JD Jr, Kuehl WM, et al
     Methylation and expression of the p16INK4A tumor suppressor gene in multiple myeloma.
     Blood. 2007;109:1337-8.
     PubMed     Related articles   
     
     
     
190. MCEARCHERN JA , Oflazoglu E, Francisco L, McDonagh CF, et al
     Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities.
     Blood. 2007;109:1185-92.
     PubMed     Related articles    Abstract available
     
     
     
191. CHAUHAN D , Neri P, Velankar M, Podar K, et al
     Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).
     Blood. 2007;109:1220-7.
     PubMed     Related articles    Abstract available
     
     
     
192. GONZALEZ-PAZ N , Chng WJ, McClure RF, Blood E, et al
     Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications.
     Blood. 2007;109:1228-32.
     PubMed     Related articles    Abstract available
     
     
     January 2007
193. DAI Y , Khanna P, Chen S, Pei XY, et al
     Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
194. SAKHINA E , Glennie C, Hoyland JA, Menasce LP, et al
     Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
195. PEREZ-GALAN P , Roue G, Villamor N, Campo E, et al
     The BH3-mimetic GX15-070 synergizes with Bortezomib in Mantle Cell Lymphoma by enhancing Noxa-mediated activation of Bak.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
196. MOSKOWITZ CH , Hamlin PA, Zelenetz AD
     Response: BCL6 and outcome in diffuse large B-cell lymphoma: a work in progress.
     Blood. 2007;109:845.
     PubMed     Related articles   
     
     
     
197. DUNLEAVY K , Davis RE, Landgren O, Staudt LM, et al
     BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?
     Blood. 2007;109:843-4.
     PubMed     Related articles   
     
     
     
198. GAJATE C , Mollinedo F
     Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts.
     Blood. 2007;109:711-9.
     PubMed     Related articles    Abstract available
     
     
     
199. CHATTERJEE M , Jain S, Stuhmer T, Andrulis M, et al
     STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival.
     Blood. 2007;109:720-8.
     PubMed     Related articles    Abstract available
     
     
     
200. BERTWISTLE D , Sherr CJ
     Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
     Blood. 2007;109:792-4.
     PubMed     Related articles    Abstract available
     
     
     
201. SCHWALLER J , Schneider P, Mhawech-Fauceglia P, McKee T, et al
     Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness.
     Blood. 2007;109:331-8.
     PubMed     Related articles    Abstract available
     
     
     
202. SOUABNI A , Jochum W, Busslinger M
     Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
     Blood. 2007;109:281-9.
     PubMed     Related articles    Abstract available
     
     
     
203. MESTRE-ESCORIHUELA C , Rubio-Moscardo F, Richter JA, Siebert R, et al
     Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.
     Blood. 2007;109:271-80.
     PubMed     Related articles    Abstract available
     
     
     
204. MAY KF JR , Lute K, Kocak E, Abdessalam S, et al
     Immune competence of cancer-reactive T cells generated de novo in adult tumor-bearing mice.
     Blood. 2007;109:253-8.
     PubMed     Related articles    Abstract available
     
     
     December 2006
205. DEUTSCH AJ , Aigelsreiter A, Staber PB, Beham A, et al
     MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
     Blood. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
206. WANG SS , Slager SL, Brennan P, Holly EA, et al
     Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10,211 cases and 11,905 controls from the InterLymph Consortium.
     Blood. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
207. ANDREADIS C , Gimotty PA, Wahl P, Hammond R, et al
     Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.
     Blood. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
208. WOETMANN A , Lovato P, Eriksen KW, Krejsgaard T, et al
     Non-malignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.
     Blood. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
209. MOREAUX J , Hose D, Reme T, Jourdan E, et al
     CD200 is a new prognostic factor in multiple myeloma.
     Blood. 2006;108:4194-7.
     PubMed     Related articles    Abstract available
     
     
     
210. WANG S , Hong S, Yang J, Qian J, et al
     Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells.
     Blood. 2006;108:4071-7.
     PubMed     Related articles    Abstract available
     
     
     
211. GIULIANI N , Rizzoli V, Roodman GD
     Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition.
     Blood. 2006;108:3992-6.
     PubMed